Literature DB >> 16382350

Animal models in the study of episodic hepatic encephalopathy in cirrhosis.

Rodrigo Jover1, Enriquede Madaria, Vicente Felipo, Regina Rodrigo, Asunción Candela, Antonio Compañ.   

Abstract

The availability of an animal model is crucial in studying the pathophysiological mechanisms of disease and to test possible therapies. Now, there are several models for the study of liver diseases, but there still remains a lack of a satisfactory animal model of chronic liver disease with hepatic encephalopathy (HE) and abnormalities in nitrogen metabolism, as seen in humans. In rats, two models of chronic HE are widely used: rats after portacaval anastomosis (PCA) and rats with chronic hyperammonemia. The first one mimics the situation induced in cirrhosis by collateral circulation, and has the problem of the absence of hepatocellular injury. The model of hyperammonemia is useful to study the effect of ammonia as a brain toxic substance, but also lacks liver failure. Bile-duct ligation has been used to induce cirrhosis and could also be a model of HE, probably with the addition of a precipitant factor. An ideal model of HE in chronic liver disease must have liver cirrhosis and a precipitant factor of HE; it must also show neuropathological characteristic findings of HE, neurochemical alterations in the main pathways impaired in these complications of cirrhosis, and low-grade brain edema.

Entities:  

Mesh:

Year:  2005        PMID: 16382350     DOI: 10.1007/s11011-005-7925-1

Source DB:  PubMed          Journal:  Metab Brain Dis        ISSN: 0885-7490            Impact factor:   3.584


  56 in total

1.  Problems with animal models of chronic liver disease: suggestions for improvement in standardization.

Authors:  K D Mullen; A J McCullough
Journal:  Hepatology       Date:  1989-03       Impact factor: 17.425

2.  Increased manganese concentrations in pallidum of cirrhotic patients.

Authors:  G Pomier-Layrargues; L Spahr; R F Butterworth
Journal:  Lancet       Date:  1995-03-18       Impact factor: 79.321

3.  Plasma GABA, GABA-like activity and the brain GABA-benzodiazepine receptor complex in rats with chronic hepatic encephalopathy.

Authors:  J E Maddison; P R Dodd; M Morrison; G A Johnston; G C Farrell
Journal:  Hepatology       Date:  1987 Jul-Aug       Impact factor: 17.425

4.  Long-term changes in glial fibrillary acidic protein and glutamine synthetase immunoreactivities in the supraoptic nucleus of portacaval shunted rats.

Authors:  I Suárez; G Bodega; E Arilla; B Fernández
Journal:  Metab Brain Dis       Date:  1996-12       Impact factor: 3.584

5.  Hepatic encephalopathy--definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998.

Authors:  Peter Ferenci; Alan Lockwood; Kevin Mullen; Ralph Tarter; Karin Weissenborn; Andres T Blei
Journal:  Hepatology       Date:  2002-03       Impact factor: 17.425

6.  The brain in experimental portal-systemic encephalopathy. I. Morphological changes in three animal models.

Authors:  C M Pilbeam; R M Anderson; P S Bhathal
Journal:  J Pathol       Date:  1983-08       Impact factor: 7.996

7.  Postoperative course after portacaval anastomosis in rats is determined by the portacaval pressure gradient.

Authors:  D L Coy; A Srivastava; J Gottstein; R F Butterworth; A T Blei
Journal:  Am J Physiol       Date:  1991-12

Review 8.  Manganese toxicity, dopaminergic dysfunction and hepatic encephalopathy.

Authors:  R F Butterworth; L Spahr; S Fontaine; G P Layrargues
Journal:  Metab Brain Dis       Date:  1995-12       Impact factor: 3.584

9.  Effects of chronic experimental liver dysfunction and L-tryptophan on behaviour in the rat.

Authors:  M D Tricklebank; J L Smart; D L Bloxam; G Curzon
Journal:  Pharmacol Biochem Behav       Date:  1978-08       Impact factor: 3.533

10.  Manganese and chronic hepatic encephalopathy.

Authors:  D Krieger; S Krieger; O Jansen; P Gass; L Theilmann; H Lichtnecker
Journal:  Lancet       Date:  1995-07-29       Impact factor: 79.321

View more
  5 in total

1.  Effects of cholestasis on learning and locomotor activity in bile duct ligated rats.

Authors:  Nasrin Hosseini; Hojjatallah Alaei; Mohammad Nasehi; Maryam Radahmadi; Zarrindast Mohammad Reza
Journal:  Malays J Med Sci       Date:  2014-01

2.  The effects of hyperammonemia in learning and brain metabolic activity.

Authors:  Natalia Arias; Camino Fidalgo; Vicente Felipo; Jorge L Arias
Journal:  Metab Brain Dis       Date:  2014-01-12       Impact factor: 3.584

3.  Activation of neuronal nitric oxide synthase in cerebellum of chronic hepatic encephalopathy rats is associated with up-regulation of NADPH-producing pathway.

Authors:  Santosh Singh; Surendra K Trigun
Journal:  Cerebellum       Date:  2010-09       Impact factor: 3.847

4.  Hyperammonemia and systemic inflammatory response syndrome predicts presence of hepatic encephalopathy in dogs with congenital portosystemic shunts.

Authors:  Mickey S Tivers; Ian Handel; Adam G Gow; Vicky J Lipscomb; Rajiv Jalan; Richard J Mellanby
Journal:  PLoS One       Date:  2014-01-02       Impact factor: 3.240

5.  Mapping metabolic brain activity in three models of hepatic encephalopathy.

Authors:  Natalia Arias; Marta Méndez; Camino Fidalgo; María Ángeles Aller; Jaime Arias; Jorge L Arias
Journal:  Int J Hypertens       Date:  2013-03-14       Impact factor: 2.420

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.